Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CONKO-Studiengruppe
With
Eli Lilly and Company
This open-label, multi center phase II study was conducted to investigate the efficacy and safety of the combination of 5-Fluorouracil (5-FU)/folinic acid (FA) plus gemcitabine (GFF) in patients (pts) with advanced pancreatic cancer (APC). We consequently started this study after completing the phase I trial accomplished by our CONKO- study group.
